Regulation of NF-κB signaling by caspases and MALT1 paracaspase

Cell Research

Volumn 21, Issue 1, 2011, Pages 40-54

  Staal, Jens ^a   Bekaert, Tine ^a   Beyaert, Rudi ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

apoptosis; caspases; inflammation; MALT1; NF B; paracaspase; TNF

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALT1 PROTEIN, HUMAN; TUMOR PROTEIN;

APOPTOSIS; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASES; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 78650883911     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.168     Document Type: Review

References (125)

1. Deribe YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol 2010; 17:666-672.
2. Keller M, Rüegg A, Werner S, Beer H. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008; 132:818-831.
3. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009; 138:838-854.
4. Howley B, Fearnhead HO. Caspases as therapeutic targets. J Cell Mol Med 2008; 12:1502-1516.
5. Vucic D, Dixit VM. Masking MALT1: the paracaspase's potential for cancer therapy. J Exp Med 2009; 206:2309-2312.
6. Yazdi AS, Guarda G, D'Ombrain MC, Drexler SK. Inflammatory caspases in innate immunity and inflammation. J Innate Immun 2010; 2:228-237.
7. Maelfait J, Beyaert R. Non-apoptotic functions of caspase-8. Biochem Pharmacol 2008; 76:1365-1373.
8. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007; 14:44-55.
9. Vallabhapurapu S, Karin M. Regulation and function of NF- κB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693-733.
10. Oeckinghaus A, Ghosh S. The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009; 1:a000034.
11. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-683.
12. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-260.
13. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 1996; 84:853-862.
14. Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 1997; 278:860-866.
15. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 1997; 278:866-869.
16. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF- κB activation. Cell 1997; 91:243-252.
17. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284:321-325.
18. Li ZW, Chu W, Hu Y, et al. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 1999; 189:1839-1845.
19. Yang J, Lin Y, Guo Z, et al. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat Immunol 2001; 2:620-624.
20. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346-351.
21. Shim J, Xiao C, Paschal AE, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19:2668-2681.
22. Yamazaki K, Gohda J, Kanayama A, et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci Signal 2009; 2:ra66.
23. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 2001; 293:1495-1499.
24. Xiao G, Fong A, Sun S. Induction of p100 processing by NF- κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J Biol Chem 2004; 279:30099-30105.
25. Janssens S, Tschopp J. Signals from within: the DNAdamage- induced NF-κB response. Cell Death Differ 2006; 13:773-784.
26. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304:843-846.
27. Legarda-Addison D, Hase H, O'Donnell MA, Ting AT. NEMO/IKKγ regulates an early NF-κB-independent celldeath checkpoint during TNF signaling. Cell Death Differ 2009; 16:1279-1288.
28. Tokunaga F, Sakata S, Saeki Y, et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 2009; 11:123-132.
29. Kawagoe T, Sato S, Matsushita K, et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 2008; 9:684-691.
30. Hacker H, Redecke V, Blagoev B, et al. Specificity in Tolllike receptor signaling through distinct effector functions of TRAF3 and TRAF6. Nature 2006; 439:204-207.
31. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005; 280:36560-36566.
32. Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006; 439:208-211.
33. Inohara N, Koseki T, del Peso L, et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem 1999; 274:14560-14567.
34. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 2001; 276:4812-4818.
35. McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-κBactivating and cell death-inducing kinase. J Biol Chem 1998; 273:16968-16975.
36. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 2004; 4:348-359.
37. Xia ZP, Sun L, Chen X, et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009; 461:114-119.
38. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009; 284:21777-21781.
39. Lippens S, VandenBroecke C, Van Damme E, Tschachler E, Vandenabeele P, Declercq W. Caspase-14 is expressed in the epidermis, the choroid plexus, the retinal pigment epithelium and thymic Hassall's bodies. Cell Death Differ 2003; 10:257-259.
40. Kamada S, Funahashi Y, Tsujimoto Y. Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteases. Cell Death Differ 1997; 4:473-478.
41. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75:653-660. (Pubitemid 23346364)
42. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA 1999; 96:2396-2401.
43. Denecker G, Hoste E, Gilbert B, et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9:666-674.
44. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS. Activation and substrate specificity of caspase-14. Biochemistry 2004; 43:10560-10569.
45. Leverrier S, Salvesen GS, Walsh CM. Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ 2010; doi: 10.1038/ cdd.2010.69.
46. Howard AD, Kostura MJ, Thornberry N, et al. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1β. J Immunol 1991; 147:2964-2969.
47. Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P. Caspase-1 activates nuclear factor of the κ-enhancer in B cells independently of its enzymatic activity. J Biol Chem 2004; 279:24785-24793.
48. Lamkanfi M, Denecker G, Kalai M, et al. INCA, a Novel Human Caspase recruitment domain protein that inhibits interleukin-1β generation. J Biol Chem 2004; 279:51729-51738.
49. Miggin SM, Pålsson-McDermott E, Dunne A, et al. NF-κB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci USA 2007; 104:3372-3377.
50. Sarkar A, Duncan M, Hart J, Hertlein E, Guttridge DC, Wewers MD. ASC directs NF-κB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 2006; 176:4979-4986.
51. Núñez Miguel R, Wong J, Westoll JF, et al. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signaling adaptor proteins. PLoS ONE 2007; 2:e788.
52. Ulrichts P, Bovijn C, Lievens S, Beyaert R, Tavernier J, Peelman F. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site. J Cell Sci 2010; 123:256-265.
53. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000; 403:98-103.
54. Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002; 293:722-726.
55. Kersse K, Vanden Berghe T, Lamkanfi M, Vandenabeele P. A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins. Biochem Soc Trans 2007; 35:1508-1511.
56. Kachapati K, O'Brien TR, Bergeron J, Zhang M, Dean M. Population distribution of the functional caspase-12 allele. Hum Mutat 2006; 27:975.
57. Saleh M, Mathison JC, Wolinski MK, et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006; 440:1064-1068.
58. LeBlanc PM, Yeretssian G, Rutherford N, et al. Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 2008; 3:146-157.
59. Lakshmanan U, Porter AG. Caspase-4 interacts with TNF receptor-associated factor 6 and mediates lipopolysaccharide- induced NF-κB-dependent production of IL-8 and CC chemokine ligand 4 (macrophage-inflammatory protein-1). J Immunol 2007; 179:8480-8490.
60. Boatright KM, Renatus M, Scott FL, et al. A unified model for apical caspase activation. Mol Cell 2003; 11:529-541.
61. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/ Fas)-mediated apoptosis. Curr Opin Immunol 1998; 10:545-551.
62. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001; 98:13884-13888.
63. Boatright KM, Deis C, Denault J, Sutherlin DP, Salvesen GS. Activation of caspases-8 and -10 by FLIP(L). Biochem J 2004; 382:651-657.
64. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-195.
65. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L. Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogene 2000; 19:4451-4460.
66. Hu WH, Johnson H, Shu HB. Activation of NF-κB by FADD, Casper, and caspase-8. J Biol Chem 2000; 275:10838-10844.
67. Wang H, Wang P, Sun X, et al. Cloning and characterization of a novel caspase-10 isoform that activates NF-κB activity. Biochim Biophys Acta 2007; 1770:1528-1537.
68. Chaudhary PM, Eby MT, Jasmin A, Hood L. Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and its homologs. J Biol Chem 1999; 274:19211-19219.
69. Shikama Y, Yamada M, Miyashita T. Caspase-8 and caspase- 10 activate NF-κB through RIP, NIK and IKKα kinases. Eur J Immunol 2003; 33:1998-2006.
70. Shan J, Wang P, Zhou J, Wu D, Shi H, Huo K. RIOK3 interacts with caspase-10 and negatively regulates the NF-κB signaling pathway. Mol Cell Biochem 2009; 332:113-120.
71. Lin Y, Devin A, Rodriguez Y, Liu ZG. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999; 13:2514-2526.
72. Rébé C, Cathelin S, Launay S, et al. Caspase-8 prevents sustained activation of NF-κB in monocytes undergoing macrophagic differentiation. Blood 2007; 109:1442-1450.
73. Rathore N, Matta H, Chaudhary PM. An evolutionary conserved pathway of nuclear factor-κB activation involving caspase-mediated cleavage and N-end rule pathway-mediated degradation of IκBα. J Biol Chem 2004; 279:39358-39365.
74. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006; 176:4520-4524.
75. Hasegawa M, Imamura R, Motani K, et al. Mechanism and repertoire of ASC-mediated gene expression. J Immunol 2009; 182:7655-7662.
76. Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430:213-218.
77. Salmena L, Lemmers B, Hakem A, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17:883-895.
78. Su H, Bidère N, Zheng L, et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 2005; 307:1465-1468.
79. Lemmers B, Salmena L, Bidère N, et al. Essential role for caspase-8 in Toll-like receptors and NFκB signaling. J Biol Chem 2007; 282:7416-7423.
80. Ch'en IL, Beisner DR, Degterev A, et al. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci USA 2008; 105:17463-17468.
81. Bidère N, Snow AL, Sakai K, Zheng L, Lenardo MJ. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-κB activation. Curr Biol 2006; 16:1666-1671.
82. Misra RS, Russell JQ, Koenig A, et al. Caspase-8 and c- FLIPL associate in lipid rafts with NF-κB adaptors during T cell activation. J Biol Chem 2007; 282:19365-19374.
83. Golks A, Brenner D, Krammer PH, Lavrik IN. The c-FLIPNH2 terminus (p22-FLIP) induces NF-κB activation. J Exp Med 2006; 203:1295-1305.
84. Chau H, Wong V, Chen N, et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med 2005; 202:405-413.
85. Zhang N, He Y. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 2005; 202:395-404.
86. Kawadler H, Gantz MA, Riley JL, Yang X. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 2008; 31:415-421.
87. Koenig A, Russell JQ, Rodgers WA, Budd RC. Spatial differences in active caspase-8 defines its role in T-cell activation versus cell death. Cell Death Differ 2008; 15:1701-1711.
88. Lamkanfi M, D'hondt K, Vande Walle L, et al. A novel caspase- 2 complex containing TRAF2 and RIP1. J Biol Chem 2005; 280:6923-6932.
89. Kumar S. Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more? Nat Rev Cancer 2009; 9:897-903.
90. Vakifahmetoglu-Norberg H, Zhivotovsky B. The unpredictable caspase-2: what can it do? Trends Cell Biol 2010; 20:150-159.
91. Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-κB activation in response to DNA damage. Cell 2005; 123:1079-1092.
92. Guha M, Xia F, Raskett CM, Altieri DC. Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene 2010; 29:1280-1292.
93. Barkett M, Xue D, Horvitz HR, Gilmore TD. Phosphorylation of IκB-α inhibits its cleavage by caspase CPP32 in vitro. J Biol Chem 1997; 272:29419-29422.
94. Kang KH, Lee KH, Kim MY, Choi KH. Caspase-3-mediated cleavage of the NF-κB subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis. J Biol Chem 2001; 276:24638-24644.
95. Neuzil J, Schröder A, von Hundelshausen P, et al. Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry 2001; 40:4686-4692.
96. Wong C, Chan H, Ho C, et al. Apoptotic histone modification inhibits nuclear transport by regulating RCC1. Nat Cell Biol 2009; 11:36-45.
97. Sun L, Deng L, Ea C, Xia Z, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004; 14:289-301.
98. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF- κB-dependent lymphocyte activation and development by paracaspase. Science 2003; 302:1581-1584.
99. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003; 19:749-758.
100. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93:3601-3609.
101. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway. J Biol Chem 2001; 276:19012-19019.
102. Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J Biol Chem 2004; 279:15870-15876.
103. Noels H, van Loo G, Hagens S, et al. A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2:MALT1 fusions. J Biol Chem 2007; 282:10180-10189.
104. Oeckinghaus A, Wegener E, Welteke V, et al. Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J 2007; 26:4634-4645.
105. Zhou H, Du M, Dixit VM. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 2005; 7:425-431.
106. Wu C, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc Natl Acad Sci USA 2008; 105:3023-3028.
107. Ferch U, Buschenfelde CMZ, Gewies A, et al. MALT1 directs B cell receptor-induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit. Nat Immunol 2007; 8:984-991.
108. Dong W, Liu Y, Peng J, et al. The IRAK-1-BCL10-MALT1- TRAF6-TAK1 cascade mediates signaling to NF-κB from Toll-like receptor 4. J Biol Chem 2006; 281:26029-26040.
109. Gross O, Gewies A, Finger K, et al. Card9 controls a non- TLR signaling pathway for innate anti-fungal immunity. Nature 2006; 442:651-656.
110. Gross O, Grupp C, Steinberg C, et al. Multiple ITAMcoupled NK cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production. Blood 2008; 112:2421-2428.
111. Klemm S, Gutermuth J, Hültner L, et al. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor κB activation and cytokine production from mast cell degranulation. J Exp Med 2006; 203:337-347.
112. Klemm S, Zimmermann S, Peschel C, Mak TW, Ruland J. Bcl10 and Malt1 control lysophosphatidic acid-induced NF- κB activation and cytokine production. Proc Natl Acad Sci USA 2007; 104:134-138.
113. Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFκB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009; 284:6038-6042.
114. McAllister-Lucas LM, Ruland J, Siu K, et al. CARMA3/ Bcl10/MALT1- dependent NF-κB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA 2007; 104:139-144.
115. Tusche MW, Ward LA, Vu F, et al. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med 2009; 206:2671-2683.
116. Rehman AO, Wang C. CXCL12/SDF-1α activates NF-κB and promotes oral cancer invasion through the Carma3/ Bcl10/Malt1 complex. Int J Oral Sci 2009; 1:105-118.
117. Hara H, Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol 2009; 30:234-242.
118. Uren AG, O'Rourke K, Aravind LA, et al. Identification of paracaspases and metacaspases: two ancient families of caspase- like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000; 6:961-967.
119. Rebeaud F, Hailfinger S, Posevitz-Fejfar A, et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 2008; 9:272-281.
120. Coornaert B, Baens M, Heyninck K, et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat Immunol 2008; 9:263-271.
121. Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity. J Biol Chem 2009; 284:8217-8221.
122. Düwel M, Welteke V, Oeckinghaus A, et al. A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains. J Immunol 2009; 182:7718-7728.
123. Malinverni C, Unterreiner A, Staal J, et al. Cleavage by MALT1 induces cytosolic release of A20. Biochem Biophys Res Commun 2010; 400:543-547.
124. Ferch U, Kloo B, Gewies A, et al. Inhibition of MALT1 protease activity is selectively toxic for activated B celllike diffuse large B cell lymphoma cells. J Exp Med 2009; 206:2313-2320.
125. Hailfinger S, Lenz G, Ngo V, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2009; 106:19946-19951.